Perimenopausal Insomnia

2

Review clinical trials related to Perimenopausal Insomnia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Trial to Investigate the Accuracy of a Wearable Device in Collecting Data Related to Perimenopausal Symptoms in Women

The goal of this observational study is to investigate the accuracy of the device in characterizing perimenopausal and menopausal symptoms including vasomotor symptoms, anxiety, sleep quality compared to self-reported symptoms via an app. The main question it aims to answer is: What is the accuracy of the developed algorithm from the investigational device compared to daily self-report via an app in characterizing perimenopausal symptoms? Participants will be asked to wear IndentifyHer's wearable non-invasive sensor and complete a daily electronic diary and questionnaires on stress, anxiety, and sleep.

Participants needed: 110
Trial details
Age: 35-55Biological sex: FemaleType: ObservationalSponsor: IdentifyHer LimitedUpdated: Sep 18, 2025Locations: 1
Eligibility criteria

Females between 35-55 years of age, inclusive [+9]

Allergy or sensitivity to adhesive used for wearing the investigational device [+11]

Status: Not yet recruiting

Auricular Acupressure for Perimenopausal Insomnia

This clinical trial aims to determine whether auricular Acupressure therapy can improve symptomatic insomnia in perimenopausal women. Can ear acupressure therapy significantly improve sleep quality in perimenopausal women with insomnia? What medical issues or adverse reactions might participants experience during the treatment? Researchers will compare ear acupressure therapy with traditional treatments in a control group to assess its effectiveness and safety. Participants will: Receive auricular acupressure on Monday and Thursday, applying pressure for 3 consecutive days each week. This process will continue for 4 weeks, totaling 8 sessions. Record assessment points as follows: Baseline (2 weeks before treatment to Week 0), mid-treatment (2 weeks after treatment begins), end of treatment (4 weeks after treatment begins), and follow-up (4 weeks after treatment ends) for primary and secondary outcome indicators. Eight weeks after treatment concludes, only the primary outcome indicator (Insomnia Severity Index) will be recorded. This trial seeks to evaluate the potential benefits and safety profile of auricular acupressure therapy for managing insomnia in perimenopausal women.

Participants needed: 160
Trial details
Age: 45-55Biological sex: FemaleType: InterventionalSponsor: The First Affiliated Hospital of Zhejiang Chinese Medical UniversityUpdated: Apr 30, 2025Locations: 1
Eligibility criteria

Age between 45 and 55 years; [+3]

Does not meet inclusion criteria; [+7]